Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia

Biochemical and Biophysical Research Communications

Volumn 242, Issue 2, 1998, Pages 452-456

  Kottickal, Lazar V ^a   Sarada, Bopanna ^a   Ashar, Hena ^b   Chada, Kiran ^b   Nagarajan, Lalitha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 12Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 0032515337     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7984     Document Type: Article

References (21)

1. Bustin M., Reeves R. Prog. Nucl. Acid Res. and Mol. Biol. 54:1996;35-100.
2. Johnson K. R., Disney J. E., Wyatt C. R., Reeves R. Exp. Cell Res. 187:1990;69-76.
3. Lanahan A., Williams J. B., Sanders L. K., Nathans D. Mol. Cell. Biol. 12:1992;3919-3929.
4. Chiappetta G., Bandiera A., Berlingieri M. T., Visconti R., Manfioletti G., Battista S., Martinez-Tella F. J., Santoro M., Giancotti V., Fusco A. Oncogene. 10:1995;1307-1314.
5. Zhou X., Benson K. F., Ashar H. R., Chada K. Nature. 376:1995;771-774.
6. Chau K. Y., Patel U. A., Lee K. L., Lam H. Y. Nucl. Acids Res. 23:1995;4262-4266.
7. Zhou X., Benson K. F., Przybysz K., Liu J., Hou Y., Cherath L., Chada K. Nucl. Acid Res. 24:1996;4071-4077.
8. Ashar H. R., Cherath L., Przybysz K. M., Chada K. Genomics. 31:1996;207-214.
9. Ashar H. R., Schoenberg, Fejzo M., Tkachenko A., Zhou X., Fletcher J. A., Weremowicz S., Morton C. C., Chada K. Cell. 82:1995;57-65.
10. Schoenmakers E. F., Wanschura S., Mols R., Bullerdiek J., Van Den Berghe H., Van de Ven W. J. Nature Genet. 10:1995;436-444.
11. Kazmierczak B., Wanschura S., Rosigkeit J., Meyer-Bolte K., Uschinsky K., Haupt R., Schoenmakers E. F., Bartnitzke S., Van de Ven W. J., Bullerdiek J. Cancer Res. 55:1995;6038-6039.
12. Kazmierczak B., Hennig Y., Wanschura S., Rogalla P., Bartnitzke S., Van de Ven W., Bullerdiek J. Cancer Res. 55:1995;2497-2499.
13. Wanschura S., Kazmierczak B., Pohnke Y., Meyer-Bolte K., Bartnitzke S., Van de Ven W. J., Bullerdiek J. Cancer Letters. 102:1996;17-21.
14. Berlingieri M. T., Manfioletti G., Santoro M., Bandiera A., Visconti R., Giancotti V., Fusco A. Mol. Cell. Biol. 15:1995;1545-1553.
15. Mitelman F. Catalog of Chromosome Aberrations in Cancer. 1994;Wiley-Liss, New York.
16. Chomczynski P., Sacchi N. Analytical Biochem. 162:1987;156-159.
17. Frohman M. A. PCR Protocols: A Guide to Methods and Applications. 1990;Academic Press, San Diego. p. 28-38.
18. Thanos D., Maniatis T. Cell. 83:1995;1091-1100.
19. Falvo J. V., Thanos D., Maniatis T. Cell. 83:1995;1101-1111.
20. Caligiuri M. A., Strout M. P., Schichman S. A., Mrozek K., Arthur D. C., Herzig G. P., Baer M. R., Schiffer C. A., Heinonen K., Knuutila S., Nousiainen T., Ruutu T., Block A. W., Schulman P., Pedersen-Bjergaard J., Croce C. M., Bloomfield C. D. Cancer Res. 56:1996;1418-1425.
21. Tkachuk D. C., Kohler S., Cleary M. L. Cell. 71:1992;691-700.